FindTrial
Sign In

first-line chemotherapy

DRUG6 trials

Sponsors

Hebei Tumor Hospital, National Cancer Institute, Naples, Chinese PLA General Hospital, Medical College of Wisconsin, Peking University People's Hospital

Conditions

Advanced Pancreatic Ductal AdenocarcinomaCancer Anorexia-Cachexia SyndromeClinical ResponseColorectal Cancer Stage IVExtensive-stage Small Cell Lung CancerHistopathological ResponsePancreatic CancerPrognosis

Phase 2

Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer
NCT01757366
Hebei Tumor HospitalSelf Efficacy
Start: 2012-12-31End: 2016-12-31Target: 100Updated: 2014-04-01
Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer
NCT02772107
Chinese PLA General HospitalExtensive-stage Small Cell Lung Cancer
Start: 2015-12-31End: 2018-01-31Target: 132Updated: 2016-05-17
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial
RecruitingNCT03322995
Medical College of WisconsinPancreatic Cancer
Start: 2018-06-21End: 2032-06-01Target: 125Updated: 2026-01-08

Unknown Phase

PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment
NCT02618850
National Cancer Institute, NaplesColorectal Cancer Stage IV
Start: 2014-04-30End: 2024-12-31Target: 260Updated: 2023-03-24
Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone
CompletedNCT03742063
Peking University People's HospitalClinical Response, Histopathological Response, Prognosis
Start: 2017-06-01End: 2018-10-30Updated: 2019-04-10
Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer
RecruitingNCT07408505
Shandong Cancer Hospital and InstituteAdvanced Pancreatic Ductal Adenocarcinoma, Cancer Anorexia-Cachexia Syndrome
Start: 2026-06-01End: 2028-02-20Target: 56Updated: 2026-04-27